VOQUEZNA CAN KICK SOME ACID
VOQUEZNA (vonoprazan) is the first and only FDA-approved potassium-competitive acid blocker (PCAB) proven to help relieve heartburn in adults with Non-Erosive Gastroesophageal Reflux Disease (GERD) or Erosive Esophagitis (EE) and help heal and maintain healing of EE.
Proven to help relieve heartburn in adults with
non-erosive GERD or Erosive Esophagitis
PROVEN TO HELP RELIEVE HEARTBURN IN ADULTS WITH NON-EROSIVE GERD AND EROSIVE ESOPHAGITIS
Heartburn relief in adults with NON-EROSIVE GERD
In a clinical trial of adults with Non-Erosive GERD taking VOQUEZNA, subjects were asked to keep track of the days they experienced heartburn and the severity of heartburn symptoms. Diaries were checked at the end of treatment to identify how many days were reported to be heartburn free.
During the 4-week clinical trial, 45% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 28% of days on placebo).
Heartburn relief in adults with EROSIVE ESOPHAGITIS
In a clinical trial, adults with EE taking VOQUEZNA were asked to keep track of the days they experienced heartburn and the severity of heartburn symptoms. Diaries were checked at the end of treatment to identify how many days were reported to be heartburn free.
During the 2-month healing phase, 67% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 64% of days on another treatment*). Over the 6-month maintenance phase, 81% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 79% of days on another treatment*).
*lansoprazole
PROVEN TO HELP HEAL AND MAINTAIN HEALING OF EROSIVE ESOPHAGITIS FOR MOST ADULTS
VOQUEZNA was evaluated in a clinical trial of adults with endoscopically confirmed EE. One group took VOQUEZNA 20 mg once daily for 2 to 8 weeks during the healing phase. 93% of adults taking VOQUEZNA for EE experienced healing by 2 months (compared to 85% taking another treatment*).
Some adults who were healed by VOQUEZNA or another treatment during the healing phase then took VOQUEZNA 10 mg once daily for up to 6 months during the maintenance phase. 79% of those stayed healed for 6 months on VOQUEZNA maintenance treatment (compared to 72% taking another treatment*).
HEALING IN MOST ADULTS WITH MODERATE AND EVEN SEVERE EROSIVE ESOPHAGITIS FROM 2 WEEKS ONWARD
VOQUEZNA has shown success in EE healing in most adults, including moderate to severe cases of esophageal erosion. 70% of adults taking VOQUEZNA 20 mg for moderate to severe EE damage achieved healing by 2 weeks (compared to 53% taking another treatment*). 92% of adults taking VOQUEZNA 20 mg for moderate to severe EE damage achieved healing by 2 months (compared to 72% taking another treatment,* but this should not be viewed as evidence of superiority).
Some adults who were healed by VOQUEZNA or another treatment during the healing phase then took VOQUEZNA 10 mg once daily for 6 months during the maintenance phase. 75% of those who took VOQUEZNA stayed healed after 6 months on maintenance treatment (compared to 61% on another treatment*).
*lansoprazole
OUR ONLINE
PHARMACY PARTNER
OUR ONLINE PHARMACY PARTNER
If your doctor sends your prescription through BlinkRx, BlinkRx can help find the lowest out-of-pocket cost available to you while offering convenient, free home delivery.
VOQUEZNA CAN KICK SOME ACID AND HELP HEAL AND MAINTAIN
HEALING OF EE FOR MOST ADULTS
VOQUEZNA was evaluated in a clinical study of adults with endoscopically confirmed EE. One group took VOQUEZNA 20 mg once daily for 2 to 8 weeks during the healing phase. 93% of adults taking VOQUEZNA for EE experienced healing by 2 months (compared to 85% taking another treatment*).
Some adults who were healed by VOQUEZNA or another treatment during the healing phase then took VOQUEZNA 10 mg once daily for up to 6 months during the maintenance phase. 79% of those stayed healed for 6 months on VOQUEZNA maintenance treatment (compared to 72% taking another treatment*).
VOQUEZNA showed healing in most adults with
moderate to severe EE from 2 weeks onward
VOQUEZNA has shown success in EE healing in most adults, including moderate to severe cases of esophageal erosion. 70% of adults taking VOQUEZNA 20 mg for moderate to severe EE damage achieved healing by 2 weeks (compared to 53% taking another treatment*). 92% of adults taking VOQUEZNA 20 mg for moderate to severe EE damage achieved healing by 2 months (compared to 72% taking another treatment,* but this should not be viewed as evidence of superiority).
Some adults who were healed by VOQUEZNA or another treatment during the healing phase then took VOQUEZNA 10 mg once daily for up to 6 months during the maintenance phase. 75% of those who took VOQUEZNA stayed healed after 6 months on maintenance treatment (compared to 61% on another treatment*).
Effective heartburn relief for most adults with EE
*lansoprazole
In a clinical study, adults with EE taking VOQUEZNA were asked to keep track of the days they experienced heartburn and the severity of heartburn symptoms. Diaries were checked after 2 months to identify how many days were reported to be heartburn free. Diaries were checked after 6 months for adults who were healed in the healing phase of the trial. During the 2-month healing phase, 67% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 64% of days on another treatment*). Over the 6-month healing phase, 81% of days spent on VOQUEZNA were heartburn free for 24 hours (compared to 79% of days on another treatment*).
*lansoprazole
Our online
pharmacy partner
If your doctor sends your prescription through BlinkRx, they can help find the lowest out-of-pocket cost available to you. They also offer convenient, free home delivery.